184 related articles for article (PubMed ID: 8814057)
1. Antibodies to beta 2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus.
Tsutsumi A; Matsuura E; Ichikawa K; Fujisaku A; Mukai M; Kobayashi S; Koike T
Arthritis Rheum; 1996 Sep; 39(9):1466-74. PubMed ID: 8814057
[TBL] [Abstract][Full Text] [Related]
2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
Musial J; Swadzba J; Motyl A; Iwaniec T
J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
[TBL] [Abstract][Full Text] [Related]
4. [Anti-beta 2-glycoprotein I antibodies and systemic lupus erythematosus].
Antolín J; Almeida D; Amérigo MJ; Cantabrana A; Roces A; Hayeck M
Med Clin (Barc); 2002 Sep; 119(9):331-2. PubMed ID: 12356362
[TBL] [Abstract][Full Text] [Related]
5. Anti beta 2glycoprotein I antibodies and lupus anticoagulant in patients with recurrent pregnancy loss: prevalence and clinical significance.
Ogasawara M; Aoki K; Matsuura E; Sasa H; Yagami Y
Lupus; 1996 Dec; 5(6):587-92. PubMed ID: 9116701
[TBL] [Abstract][Full Text] [Related]
6. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
Swadzba J; De Clerck LS; Stevens WJ; Bridts CH; van Cotthem KA; Musial J; Jankowski M; Szczeklik A
J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792
[TBL] [Abstract][Full Text] [Related]
7. Anti-beta 2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndrome.
Teixidó M; Font J; Reverter JC; Cervera R; Tàssies D; Ingelmo M; Escolar G; Ordinas A
Br J Rheumatol; 1997 Jan; 36(1):113-6. PubMed ID: 9117149
[TBL] [Abstract][Full Text] [Related]
8. IgA class anti-beta2-glycoprotein I in patients with systemic lupus erythematosus.
Tsutsumi A; Matsuura E; Ichikawa K; Fujisaku A; Mukai M; Koike T
J Rheumatol; 1998 Jan; 25(1):74-8. PubMed ID: 9458206
[TBL] [Abstract][Full Text] [Related]
9. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
Arnout J
Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
[TBL] [Abstract][Full Text] [Related]
10. Serum anti-beta2-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients.
Gómez-Pacheco L; Villa AR; Drenkard C; Cabiedes J; Cabral AR; Alarcón-Segovia D
Am J Med; 1999 Apr; 106(4):417-23. PubMed ID: 10225244
[TBL] [Abstract][Full Text] [Related]
11. Increased levels of beta 2 glycoprotein-I antigen and beta 2 glycoprotein-I binding antibodies are associated with a history of thromboembolic complications in patients with SLE and primary antiphospholipid syndrome.
McNally T; Mackie IJ; Machin SJ; Isenberg DA
Br J Rheumatol; 1995 Nov; 34(11):1031-6. PubMed ID: 8542203
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
[TBL] [Abstract][Full Text] [Related]
13. Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome.
Parkpian V; Verasertniyom O; Vanichapuntu M; Totemchokchyakarn K; Nantiruj K; Pisitkul P; Angchaisuksiri P; Archararit N; Rachakom B; Ayurachai K; Janwityanujit S
Clin Rheumatol; 2007 Oct; 26(10):1663-70. PubMed ID: 17332980
[TBL] [Abstract][Full Text] [Related]
14. IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome.
Tubach F; Hayem G; Marchand JL; Weber M; Palazzo E; de Bandt M; Roux S; Kahn MF; Meyer O
J Rheumatol; 2000 Jun; 27(6):1437-43. PubMed ID: 10852267
[TBL] [Abstract][Full Text] [Related]
15. Antiphospholipid antibody tests: spreading the net.
Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
[TBL] [Abstract][Full Text] [Related]
16. Isotypes of anti-beta2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus.
Lee SS; Cho ML; Joo YS; Kim WU; Hong YS; Min JK; Lee SH; Park SH; Cho CS; Kim HY
J Rheumatol; 2001 Mar; 28(3):520-4. PubMed ID: 11296952
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of anticardiolipin antibody in patients with systemic lupus erythematosus and its association with clinical manifestations.
Basiri Z; Gholyaf M; Faridnia M; Nadi E; Bairanvand M
Acta Med Iran; 2013; 51(1):35-40. PubMed ID: 23456582
[TBL] [Abstract][Full Text] [Related]
18. Anti beta 2 glycoprotein I antibodies: detection and association with thrombosis.
Martinuzzo ME; Forastiero RR; Carreras LO
Br J Haematol; 1995 Feb; 89(2):397-402. PubMed ID: 7873391
[TBL] [Abstract][Full Text] [Related]
19. Anti-beta 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome?
Balestrieri G; Tincani A; Spatola L; Allegri F; Prati E; Cattaneo R; Valesini G; Del Papa N; Meroni P
Lupus; 1995 Apr; 4(2):122-30. PubMed ID: 7795615
[TBL] [Abstract][Full Text] [Related]
20. Clinical importance of antibodies against platelet activating factor in antiphospholipid syndrome manifestations.
Tektonidou MG; Petrovas CA; Ioannidis JP; Vlachoyiannopoulos PG; Moutsopoulos HM
Eur J Clin Invest; 2000 Jul; 30(7):646-52. PubMed ID: 10886305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
